Capricor Therapeutics
CAPR
#4813
Rank
A$2.56 B
Marketcap
A$47.20
Share price
-0.45%
Change (1 day)
128.49%
Change (1 year)

Earnings for Capricor Therapeutics (CAPR)

Earnings in 2025 (TTM): -A$0.13 Billion

According to Capricor Therapeutics 's latest financial reports the company's current earnings are A$11.13 Million. In 2024 the company made an earning of -A$57.15 Million a decrease over its 2023 earnings that were of -A$31.48 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Capricor Therapeutics from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.13 Billion122.36%
2024 -A$57.15 Million81.57%
2023 -A$31.48 Million-23.2%
2022 -A$40.99 Million44.93%
2021 -A$28.28 Million46.61%
2020 -A$19.29 Million78.71%
2019 -A$10.8 Million-49.7%
2018 -A$21.46 Million-724.78%
2017 A$3.43 M-112.93%
2016 -A$26.56 Million46.27%
2015 -A$18.16 Million106.82%
2014 -A$8.78 Million-48.41%
2013 -A$17.02 Million977.23%
2012 -A$1.58 Million-77.11%
2011 -A$6.91 Million-22.35%
2010 -A$8.89 Million-20.17%
2009 -A$11.14 Million-41.17%
2008 -A$18.93 Million41.05%
2007 -A$13.42 Million1098.87%
2006 -A$1.12 Million4101.55%
2005 -A$0.03 Million-0.97%
2004 -A$0.03 Million17.87%
2003 -A$0.03 Million3.66%
2002 -A$0.03 Million-30.11%
2001 -A$0.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$45.74 B-39,612.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
A$0.82 B-811.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-A$1.07 Billion 817.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-A$0.37 Billion 212.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-A$6.78 Million-94.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-A$13.41 Million-88.43%๐Ÿ‡บ๐Ÿ‡ธ USA